# DENEX, Renal Denervation Therapy, in Patients With Hypertension on no or 1-3 Antihypertensive Medications

Study · id `cardio:ct-nct04307836` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04307836](<https://clinicaltrials.gov/study/NCT04307836>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04307836

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.

## Technical summary

Registry record NCT04307836. Randomized; no masking; primary purpose treatment. Start 2020-07-09 (actual); primary completion 2023-07-17 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 140 participants (planned count; ClinicalTrials.gov record NCT04307836, source copy `cardio:ctgov-nct04307836-2023-10-06`, retrieved 2026-10-26)
- Started: 2020-07-09 (actual) (ClinicalTrials.gov record NCT04307836, source copy `cardio:ctgov-nct04307836-2023-10-06`, retrieved 2026-10-26)
- Primary completion: 2023-07-17 (actual) (ClinicalTrials.gov record NCT04307836, source copy `cardio:ctgov-nct04307836-2023-10-06`, retrieved 2026-10-26)
- Completion: 2024-04-17 (anticipated) (ClinicalTrials.gov record NCT04307836, source copy `cardio:ctgov-nct04307836-2023-10-06`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT04307836, source copy `cardio:ctgov-nct04307836-2023-10-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04307836-2023-10-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: DENEX, Renal Denervation Therapy, in Patients With Hypertension on no or 1-3 Antihypertensive Medications
- Condition: Hypertension
- Condition: Vascular Diseases
- Condition: Cardiovascular Diseases
- Intervention (Device): Renal Denervation
- Lead sponsor: Kalos Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: c902fa081c2239ec7cd87f34440e77523b0cc37e18971c7e8a9909119e2a1c1d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
